A Study of Nanvuranlat in People With Biliary Tract Cancer

Full Title

A Phase 3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients with Previously Treated Advanced Biliary Tract Cancer

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Ghassan Abou-Alfa’s office at 646-888-4184.

Protocol
26-196
Phase
Phase III (phase 3)
Disease Status
Relapsed or Refractory
Investigator
Ghassan K. Abou-Alfa
Co-Investigators
James J. Harding
Diseases
Hepatobiliary
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07265674
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description